💨 Abstract

The Delhi High Court ordered the owner of Medserve to pay a compensation of Rs 3.34 crore to Johnson & Johnson for selling counterfeit medical products. The court awarded Rs 2.34 crore in compensatory damages and Rs 1 crore in exemplary damages. The counterfeit products, including surgical sutures, were found to be substandard and posed a significant threat to public health.

Courtesy: theprint.in

Summarized by Einstein Beta 🤖

Powered by MessengerX.io